Accountable interventional pain management: A collaboration among practitioners, patients, payers, and government

Pain Physician

Volumn 16, Issue 6, 2013, Pages

  Manchikanti, Laxmaiah ^a,b   Helm II, Standiford ^c   Singh, Vijay ^d   Hirsch, Joshua A ^e  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c The Helm Center for Pain Management   (United States)

^d Spine Pain Diagnostics Associates   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Accountable interventional pain management; Coverage advisory committee; Epidural injections; Facet joint interventions; Medicare; Medicare evidence development; Payment policies; Sacroiliac joint injections

Indexed keywords

ANALGESIC AGENT;

ARTICLE; CHRONIC PAIN; DECOMPRESSION SURGERY; DISKOGRAPHY; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MEDICARE; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PREVALENCE; SPINAL PAIN; SPINE SURGERY; SURGICAL TECHNIQUE;

HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH; PAIN MANAGEMENT; UNITED STATES;

EID: 84888116319     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (235)

1. Institute of Medicine (IOM). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. The National Academies Press, Washington, DC, June 29, 2011. www.iom.edu/-/media/Files/Report%20 Files/2011/Relieving-Pain-in-America-ABlueprint-for-Transforming-Prevention-Care-Education-Research/Pain%20Research% 202011%20Report%20Brief.pdf
2. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain 2012; 13:715-724.
3. US Burden of Disease Collaborators. The state of US health, 1999-2010: Burden of diseases, injuries, and risk factors. JAMA 2013; 310:591-608.
4. Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, Castel LD, Kalsbeek WD, Carey TS. The rising prevalence of chronic low back pain. Arch Intern Med 2009; 169:251-258.
5. Hoy D, Brooks P, Blyth F, Buchbinder R. The epidemiology of low back pain. Best Pract Res Clin Rheumatol 2010; 24:769-781.
6. Hoy DG, Protani M, De R, Buchbinder R. The epidemiology of neck pain. Best Pract Res Clin Rheumatol 2010; 24:783-792.
7. Leigh JP. Economic burden of occupational injury and illness in the United States. Milbank Q 2011; 89:728-772.
8. Bhushan A, Leigh JP. National trends in occupational injuries before and after 1992 and predictors of workers' compensation costs. Public Health Rep 2011; 126:625-634.
9. U.S. Social Security Administration. Annual statistical report on the Social Security Disability Insurance Program, 2011. Release July 2012. www.ssa.gov/policy/docs/ statcomps/di_asr/2011/di_asr11.pdf
10. Saastamoinen P, Leino-Arjas P, Laaksonen M, Lahelma E. Socio-economic differences in the prevalence of acute, chronic and disabling chronic pain among ageing employees. Pain 2005; 114:364-371.
11. Manchikanti L, Hirsch JA. Lessons learned in the abuse of pain relief medication: A focus on health care costs. Expert Rev Neurother 2013; 13:527-544.
12. Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM, Bryce DA, Burks PA, Caraway DL, Calodney AK, Cash KA, Christo PJ, Cohen SP, Colson J, Conn A, Cordner HJ, Coubarous S, Datta S, Deer TR, Diwan SA, Falco FJE, Fellows B, Geffert SC, Grider JS, Gupta S, Hameed H, Hameed M, Hansen H, Helm II S, Janata JW, Justiz R, Kaye AD, Lee M, Manchikanti KN, McManus CD, Onyewu O, Parr AT, Patel VB, Racz GB, Sehgal N, Sharma M, Simopoulos TT, Singh V, Smith HS, Snook LT, Swicegood J, Vallejo R, Ward SP, Wargo BW, Zhu J, Hirsch JA. An update of comprehensive evidence-based guidelines for interventional techniques of chronic spinal pain: Part II: Guidance and recommendations. Pain Physician 2013; 16:S49-S283.
13. Martin BI, Deyo RA, Mirza SK, Turner JA, Comstock BA, Hollingworth W, Sullivan SD. Expenditures and health status among adults with back and neck problems. JAMA 2008; 299:656-664. Erratum in: JAMA 2008; 299:2630.
14. Martin BI, Turner JA, Mirza SK, Lee MJ, Comstock BA, Deyo RA. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006. Spine (Phila Pa 1976) 2009; 34:2077-2084.
15. Rajaee SS, Bae HW, Kanim LE, Delamarter RB. Spinal fusion in the United States: Analysis of trends from 1998 to 2008. Spine (Phila Pa 1976) 2012; 37:67-76.
16. Bae HW, Rajaee SS, Kanim LE. Nationwide trends in the surgical management of lumbar spinal stenosis. Spine (Phila Pa 1976). 2013;38:916-926.
17. Kim CH, Chung CK, Park CS, Choi B, Kim MJ, Park BJ. Reoperation rate after surgery for lumbar herniated intervertebral disc disease: Nationwide cohort study. Spine (Phila Pa 1976) 2013; 38:581-590.
18. Ohtori S, Koshi T, Yamashita M, Yamauchi K, Inoue G, Suzuki M, Orita S, Eguchi Y, Ochiai N, Kishida S, Takaso M, Kuniyoshi K, Aoki Y, Ishikawa T, Arai G, Miyagi M, Kamoda H, Suzuki M, Nakamura J, Toyone T, Takahashi K. Surgical versus nonsurgical treatment of selected patients with discogenic low back pain: A small-sized randomized trial. Spine (Phila Pa 1976) 2011; 36:347-354.
19. Madan S, Gundanna M, Harley JM, Boeree NR, Sampson M. Does provocative discography screening of discogenic back pain improve surgical outcome? J Spinal Disord Tech 2002; 15:245-251.
20. Kovacs FM, Urrútia G, Alarcón JD. Surgery versus conservative treatment for symptomatic lumbar spinal stenosis: A systematic review of randomized controlled trials. Spine (Phila Pa 1976) 2011; 36:E1335-E1351.
21. Jacobs WC, van Tulder M, Arts M, Rubinstein SM, van Middelkoop M, Ostelo R, Verhagen A, Koes B, Peul WC. Surgery versus conservative management of sciatica due to a lumbar herniated disc: A systematic review. Eur Spine J 2011; 20:513-522.
22. Patil PG, Turner DA, Pietrobon R. National trends in surgical procedures for degenerative cervical spine disease: 1990-2000. Neurosurgery 2005; 57:753-758.
23. Oglesby M, Fineberg SJ, Patel AA, Pelton MA, Singh K. Epidemiological trends in cervical spine surgery for degenerative diseases between 2002 and 2009. Spine (Phila Pa 1976) 2013; 38:1226-1232.
24. Boselie TF, Willems PC, van Mameren H, de Bie RA, Benzel EC, van Santbrink H. Arthroplasty versus fusion in single-level cervical degenerative disc disease: a Cochrane review. Spine (Phila Pa 1976) 2013; 38:E1096-E1107
25. Wang TY, Lubelski D, Abdullah KG, Steinmetz MP, Benzel EC, Mroz TE. Rates of anterior cervical discectomy and fusion after initial posterior cervical foraminotomy. Spine J 2013; [Epub ahead of print].
26. Fineberg SJ, Oglesby M, Patel AA, Pelton MA, Singh K. Outcomes of cervical spine surgery in teaching and non-teaching hospitals. Spine (Phila Pa 1976) 2013; 38:1089-1096.
27. Shamji MF, Cook C, Pietrobon R, Tackett S, Brown C, Isaacs RE. Impact of surgical approach on complications and resource utilization of cervical spine fusion: A nationwide perspective to the surgical treatment of diffuse cervical spondylosis. Spine J 2009; 9:31-38.
28. Cunningham MR, Hershman S, Bendo J. Systematic review of cohort studies comparing surgical treatments for cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2010; 35:537-543.
29. Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Hanscom B, Skinner JS, Abdu WA, Hilibrand AS, Boden SD, Deyo RA. Surgical vs nonoperative treatment for lumbar disk herniation: The Spine Patient Outcomes Research Trial (SPORT): A randomized trial. JAMA 2006; 296:2441-2450.
30. Weinstein JN, Lurie JD, Tosteson TD, Skinner JS, Hanscom B, Tosteson AN, Herkowitz H, Fischgrund J, Cammisa FP, Albert T, Deyo RA. Surgical vs nonoperative treatment for lumbar disk herniation. The Spine Patient Outcomes Research Trial (SPORT): Observational cohort. JAMA. 2006; 296:2451-2459.
31. van Middelkoop M, Rubinstein SM, Kuijpers T, Verhagen AP, Ostelo R, Koes BW, van Tulder MW. A systematic review on the effectiveness of physical and rehabilitation interventions for chronic nonspecific low back pain. Eur Spine J 2011; 20:19-39.
32. Rubinstein SM, van Middelkoop M, Assendelft WJ, de Boer MR, van Tulder MW. Spinal manipulative therapy for chronic low-back pain: An update of a Cochrane review. Spine (Phila Pa 1976) 2011; 36:E825-E846.
33. Tosteson AN, Tosteson TD, Lurie JD, Abdu W, Herkowitz H, Andersson G, Albert T, Bridwell K, Zhao W, Grove MR, Weinstein MC, Weinstein JN. Comparative effectiveness evidence from the spine patient outcomes research trial: Surgical versus nonoperative care for spinal stenosis, degenerative spondylolisthesis, and intervertebral disc herniation. Spine (Phila Pa 1976) 2011; 36:2061-2068.
34. Baaj AA, Downes K, Vaccaro AR, Uribe JS, Vale FL. Trends in the treatment of lumbar spine fractures in the United States: A socioeconomics perspective: Clinical article. J Neurosurg Spine 2011; 15:367-370.
35. Davis MA, Sirovich BE, Weeks WB. Utilization and expenditures on chiropractic care in the United States from 1997 to 2006. Health Serv Res 2010; 45:748-761.
36. Machlin SR, Chevan J, Yu WW, Zodet MW. Determinants of utilization and expenditures for episodes of ambulatory physical therapy among adults. Phys Ther 2011; 91:1018-1029.
37. Fritz JM, Childs JD, Wainner RS, Flynn TW. Primary care referral of patients with low back pain to physical therapy: Impact on future health care utilization and costs. Spine (Phila Pa 1976) 2012; 37:2114-2121.
38. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. Adverse effects associated with highdose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 2006; 31:542-547.
39. Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, Helfand M. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: A systematic review and meta-analysis. Ann Intern Med 2013; 158:890-902.
40. Simmonds MC, Brown JV, Heirs MK, Higgins JP, Mannion RJ, Rodgers MA, Stewart LA. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: A meta-analysis of individual-participant data. Ann Intern Med 2013; 158:877-889.
41. Manchikanti L, Pampati V, Falco FJE, Hirsch JA. Growth of spinal interventional pain management techniques: Analysis of utilization trends and Medicare expenditures 2000 to 2008. Spine (Phila Pa 1976) 2013; 38:157-168.
42. Manchikanti L, Falco FJE, Singh V, Pampati V, Parr AT, Benyamin RM, Fellows B, Hirsch JA. Utilization of interventional techniques in managing chronic pain in the Medicare population: Analysis of growth patterns from 2000 to 2011. Pain Physician 2012; 15:E969-E982.
43. Abbott ZI, Nair KV, Allen RR, Akuthota VR. Utilization characteristics of spinal interventions. Spine J 2012; 1:35-43.
44. Chou R, Huffman L. Guideline for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain: Evidence Review. American Pain Society; Glenview, IL: 2009. www.americanpainsociety.org/uploads/ pdfs/Opioid_Final_Evidence_Report.pdf
45. Chou R, Huffman L. Guideline for the Evaluation and Management of Low Back Pain: Evidence Review. American Pain Society, Glenview, IL, 2009. www.americanpainsociety. org/uploads/pdfs/LBPEvidRev.pdf
46. Manchikanti L, Helm II S, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV. Opioid epidemic in the United States. Pain Physician 2012; 15:ES9-ES38.
47. Manchikanti L, Hirsch JA. The pains of chronic opioid usage [Spotlight]. AHRQ WebM&M [serial online]. September 2013. h t t p: / / w e b m m. a h r q. g o v/ c a s e. aspx?caseID=305
48. Manchikanti L, Pampati V, Hirsch JA. Analysis of utilization patterns of vertebroplasty and kyphoplasty in the Medicare population. J Neurointervent Surg 2013; 5:467-472.
49. US Department of Health and Human Services. Office of Inspector General (OIG). Medicare Payments for Facet Joint Injection Services (OEI-05-07-00200). September 2008. www.oig.hhs.gov/oei/ reports/oei-05-07-00200.pdf
50. US Department of Health and Human Services. Office of Inspector General (OIG). Inappropriate Medicare Payments for Transforaminal Epidural Injection Services (OEI-05-09-00030). August 2010. http://oig.hhs.gov/oei/reports/oei-05-09-00030.pdf
51. The National Uniform Claims Committee. Specialty Designation for Interventional Pain Management-09.
52. Medicare Payment Advisory Commission Report to the Congress. Paying for Interventional Pain Services in Ambulatory Settings. December 2001.
53. Department of Health and Human Services Centers for Medicare & Medicaid Services. 42 CFR Parts 405, 409, 410, 411, 413, 414, 415, and 424. Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Final Rule. November 29, 2010.
54. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 414, 415, and 495. Medicare Program; Payment Policies under the Physician Fee Schedule, Five-Year Review of Work Relative Value Units, Clinical Laboratory Fee Schedule: Signature on Requisition, and Other Revisions to Part B for CY 2012. January 4, 2012.
55. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 416, 419, 476, 478, 480, and 495. Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Electronic Reporting Pilot; Inpatient Rehabilitation Facilities Quality Reporting Program; Revision to Quality Improvement Organization Regulations. CY 2013; Final Rule. November 15, 2012.
56. Manchikanti L, Falco FJE, Benyamin RM, Helm II S, Singh V, Hirsch JA. Value-based interventional pain management: A review of Medicare national and local coverage determination policies. Pain Physician 2013; 16:E145-E180.
57. Manchikanti L, Helm II S, Hirsch JA. The evolution of the Patient-Centered Outcome Research Institute. J Neurointervent Surg 2012; 4:157-162.
58. Manchikanti L, Hirsch JA. The Independent Payment Advisory Board: Impact on neurointerventionalists. J Neurointerv Surg 2012; 4:468-472.
59. Organisation for Economic Co-operation and Development (OECD). OECD Health Data 2013-Frequently Requested Data. www.oecd.org/els/health-systems/oecdhealthdata2013-frequentlyrequesteddata. htm
60. World Health Organization. Global health expenditure database. www.who.int/nha/ expenditure_database/en/
61. Antos JR, Pauly MV, Wilensky GR. Bending the cost curve through market-based incentives. N Engl J Med 2012; 367:954-958.
62. Keehan SP, Cuckler GA, Sisko AM, Madison AJ, Smith SD, Lizonitz JM, Poisal JA, Wolfe CJ. National health expenditure projections: Modest annual growth until coverage expands and economic growth accelerates. Health Aff (Millwood) 2012; 31:1600-1612.
63. Public Law No: 111-148: H.R. 3590. Patient Protection and Affordable Care Act. March 23, 2010.
64. Manchikanti L, Hirsch JA. Obamacare 2012: Prognosis unclear for interventional pain management. Pain Physician 2012; 15:E629-E640.
65. 2013 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, May 31, 2013. www.cms.gov/Research-Statistics-Dataand-Systems/Statistics-Trends-and-Reports/ ReportsTrustFunds/Downloads/ TR2013.pdf
66. Manchikanti L, Hirsch JA. Regulatory burdens of the Affordable Care Act. Harvard Health Policy Rev 2012; 13:9-12.
67. Congressional Budget Office. Updated estimates for the insurance coverage provisions of the Affordable Care Act. March 2012. www.cbo.gov/sites/default/ files/cbofiles/attachments/03-13-Coverage% 20Estimates.pdf
68. Hoffman A, Emanuel EJ. Reengineering US health care. JAMA 2013; 309:661-662.
69. Shortell SM. Bridging the divide between health and health care. JAMA 2013; 309:1121-1122.
70. Medicare Payment Advisory Commission. Report to the Congress. Medicare and the Health Care Delivery System. Washington, DC: MedPAC. June 2013. www.medpac. gov/documents/Jun13_EntireReport. pdf
71. Chou R, Atlas SJ, Loeser JD, Rosenquist RW, Stanos SP. Guideline warfare over interventional therapies for low back pain: Can we raise the level of discourse? J Pain 2011; 12:833-839.
72. Manchikanti L, Benyamin RM, Falco FJE, Caraway DL, Datta S, Hirsch JA. Guidelines warfare over interventional techniques: Is there a lack of discourse or straw man? Pain Physician 2012; 15:E1-E26.
73. American Society of Anesthesiologists Task Force on Chronic Pain Management; American Society of Regional Anesthesia and Pain Medicine. Practice guidelines for chronic pain management: An updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology 2010; 112:810-833.
74. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G. Chapter 4: European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006; 15:S192-S300.
75. Furlan AD, Yazdi F, Tsertsvadze A, Gross A, Van Tulder M, Santaguida L, Gagnier J, Ammendolia C, Dryden T, Doucette S, Skidmore B, Daniel R, Ostermann T, Tsouros S. A systematic review and meta-analysis of efficacy, cost-effectiveness, and safety of selected complementary and alternative medicine for neck and low-back pain. Evid Based Complement Alternat Med 2012; 2012:953139.
76. Staal JB, de Bie RA, de Vet HC, Hildebrandt J, Nelemans P. Injection therapy for subacute and chronic low back pain: An updated Cochrane review. Spine (Phila Pa 1976) 2009; 34:49-59.
77. Pinto RZ, Maher CG, Ferreira ML, Hancock M, Oliveira VC, McLachlan AJ, Koes B, Ferreira PH. Epidural corticosteroid injections in the management of sciatica: A systematic review and meta-analysis. Ann Intern Med 2012; 157:865-877.
78. Cohen SP, Bicket MC, Jamison D, Wilkinson I, Rathmell JP. Epidural steroids: A comprehensive, evidence-based review. Reg Anesth Pain Med 2013; 38:175-200.
79. Bicket M, Gupta A, Brown CH, Cohen SP. Epidural injections for spinal pain: A systematic review and meta-analysis evaluating the "control" injections in randomized controlled trials. Anesthesiology 2013; 119:907-931.
80. Manchikanti L, Falco FJE, Hirsch JA. Epidural corticosteroid injections in the management of sciatica. Ann Intern Med 2012; 157:865-877; online comment posted March 29, 2013.
81. Roberts ST, Willick SE, Rho ME, Rittenberg JD. Efficacy of lumbosacral transforaminal epidural steroid injections: A systematic review. PM R 2009; 1:657-668.
82. Quraishi NA. Transforaminal injection of corticosteroids for lumbar radiculopathy: Systematic review and meta-analysis. Eur Spine J 2012; 21:214-219.
83. Benny B, Azari P. The efficacy of lumbosacral transforaminal epidural steroid injections: A comprehensive literature review. J Back Musculoskelet Rehabil 2011; 24:67-76.
84. Rho ME, Tang CT. The efficacy of lumbar epidural steroid injections: Transforaminal, interlaminar, and caudal approaches. Phys Med Rehabil Clin N Am 2011; 22:139-148.
85. Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of epidural steroid injections for low back pain and sciatica: A systematic review of randomized clinical trials. Pain 1995; 63:279-288.
86. Koes BW, Scholten RJ, Mens JMA, Bouter LM. Epidural steroid injections for low back pain and sciatica. An updated systematic review of randomized clinical trials. Pain Digest 1999; 9:241-247.
87. Guerts JW, van Wijk RM, Stolker RJ, Groen GJ. Efficacy of radiofrequency procedures for the treatment of spinal pain: A systematic review of randomized clinical trials. Reg Anesth Pain Med 2001; 26:394-400.
88. Niemisto L, Kalso E, Malmivaara A, Seitsalo S, Hurri H. Radiofrequency denervation for neck and back pain: A systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine (Phila Pa 1976) 2003; 28:1877-1888.
89. Macvicar J, King W, Landers MH, Bogduk N. The effectiveness of lumbar transforaminal injection of steroids: A comprehensive review with systematic analysis of the published data. Pain Med 2013; 14:14-28.
90. Bogduk N. A narrative review of intraarticular corticosteroid injections for low back pain. Pain Med 2005; 6:287-296.
91. Bogduk N, Dreyfuss P, Govind J. A narrative review of lumbar medial branch neurotomy for the treatment of back pain. Pain Med 2009; 10:1035-1045.
92. Depalma MJ, Ketchum JM, Trussell BS, Saullo TR, Slipman CW. Does the location of low back pain predict its source? PMR 2011; 3:33-39.
93. Pearson AM, Blood EA, Frymoyer JW, Herkowitz H, Abdu WA, Woodward R, Longley M, Emery SE, Lurie JD, Tosteson TD, Weinstein JN. SPORT lumbar intervertebral disk herniation and back pain: Does treatment, location, or morphology matter? Spine (Phila Pa 1976) 2008; 33:428-435.
94. van Tulder MWV, Koes BW, Bouter LM. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine (Phila Pa 1976) 1997; 22:2128-2156.
95. van Rijn RM, Wassenaar M, Verhagen AP, Ostelo RW, Ginai AZ, de Boer MR, van Tulder MW, Koes BW. Computed tomography for the diagnosis of lumbar spinal pathology in adult patients with low back pain or sciatica: A diagnostic systematic review. Eur Spine J 2012; 21:228-239.
96. Henschke N, Kuijpers T, Rubinstein SM, van Middelkoop M, Ostelo R, Verhagen A, Koes BW, van Tulder MW. Injection therapy and denervation procedures for chronic low-back pain: A systematic review. Eur Spine J 2010; 19:1425-1449.
97. Friedman JH, Dighe G. Systematic review of caudal epidural injections in the management of chronic back pain. R I Med J (2013) 2013; 96:12-16.
98. Staal JB, Nelemans PJ, de Bie RA. Spinal injection therapy for low back pain. JAMA 2013; 309:2439-2440.
99. Benoist M, Boulu P, Hayem G. Epidural steroid injections in the management of low-back pain with radiculopathy: an update of their efficacy and safety. Eur Spine J 2012; 21:204-213.
100. Gerdesmeyer L, Wagenpfeil S, Birkenmaier C, Veihelmann A, Hauschild M, Wagner K, Al Muderis M, Gollwitzer H, Diehl P, Toepfer A. Percutaneous epidural lysis of adhesions in chronic lumbar radicular pain: A prospective randomized controlled trial. Pain Physician 2013; 16:185-196.
101. Manchikanti L, Pampati V, Falco FJE, Hirsch JA. Assessment of the growth of epidural injections in the Medicare population from 2000 to 2011. Pain Physician 2013; 16:E349-E364.
102. Manchikanti L, Pampati V, Singh V, Falco FJE. Assessment of the escalating growth of facet joint interventions in the Medicare population in the United States from 2000 to 2011. Pain Physician 2013; 16:E365-E378.
103. Manchikanti L, Hansen H, Pampati V, Falco FJE. Utilization and growth patterns of sacroiliac joint injections from 2000 to 2011 in the Medicare population. Pain Physician 2013; 16:E379-E390.
104. Scanlon GC, Moeller-Bertram T, Romanowsky SM, Wallace MS. Cervical transforaminal epidural steroid injections: More dangerous than we think? Spine (Phila Pa 1976) 2007; 32:1249-1256.
105. Huntoon MA. Anatomy of the cervical intervertebral foramina: Vulnerable arteries and ischemic neurologic injuries after transforaminal epidural injections. Pain 2005; 117:104-111.
106. Malhotra G, Abbasi A, Rhee M. Complications of transforaminal cervical epidural steroid injections. Spine (Phila Pa 1976) 2009; 34:731-739.
107. Glaser SE, Falco F. Paraplegia following a thoracolumbar transforaminal epidural steroid injection. Pain Physician 2005; 8:309-314.
108. Glaser SE, Shah RV. Root cause analysis of paraplegia following transforaminal epidural steroid injections: The "unsafe" triangle. Pain Physician 2010; 13:237-244.
109. Houten JK, Errico TJ. Paraplegia after lumbosacral nerve root block: Report of three cases. Spine J 2002; 2:70-75.
110. Huntoon MA, Martin DP. Paralysis after transforaminal epidural injection and previous spinal surgery. Reg AnesthPain Med 2004; 29:494-495.
111. Somayaji HS, Saifuddin A, Casey ATH, Briggs TWR. Spinal cord infarction following therapeutic computed tomography-guided left l2 nerve root injection. Spine (Phila Pa 1976) 2005; 30:E106-E108.
112. Quintero N, Laffont I, Bouhmidi L, Rech C, Schneider AE, Gavardin T, Dizien O. Transforaminal epidural steroid injection and paraplegia: Case report and bibliographic review. Ann Readapt Med Phys 2006; 49:242-247.
113. Kennedy DJ, Dreyfuss P, Aprill CN, Bogduk N. Paraplegia following image guided transforaminal lumbar spine epidural steroid injection: Two case reports. Pain Med 2009; 10:1389-1394.
114. Lyders EM, Morris PP. A case of spinal cord infarction following lumbar transforaminal epidural steroid injection: MR imaging and angiographic findings. AJNR Am J Neuroradiol 2009; 30:1691-1693.
115. Wybier M, Gaudart S, Petrover D, Houdart E, Laredo JD. Paraplegia complicating selective steroid injections of the lumbar spine: Report of five cases and review of the literature. Eur Radiol 2010; 20:181-189.
116. Atluri S, Glaser SE, Shah RV, Sudarsha G. Needle position analysis in cases of paralysis from transforaminal epidurals: Consider alternative approaches to traditional techniques. Pain Physician 2013; 16:321-334.
117. Murthy NS, Maus TP, Behrns CL. Intraforaminal location of the great anterior radiculomedullary artery (artery of Adamkiewicz): A retrospective review. Pain Med 2010; 11:1756-1764.
118. Chang Chien GC, Candido KD, Knezevic NN. Digital subtraction angiography does not reliably prevent paraplegia associated with lumbar transforaminal epidural steroid injection. Pain Physician 2012; 15:515-523.
119. Alleyne CH Jr, Cawley CM, Shengelaia GG, Barrow DL. Microsurgical anatomy of the artery of Adamkiewicz and its segmental artery. J Neurosurg 1998; 89:791-795.
120. Kroszczynski AC, Kohan K, Kurowski M, Olson TR, Downie SA. Intraforaminal location of thoracolumbar anterior medullary arteries. Pain Med 2013; 14:808-812.
121. Rauschning W. Normal and pathological anatomy of the nerve root canals. Spine (Phila Pa 1976) 1987; 2:1008-1019.
122. van Roy P, Barbaix E, Clarijs JP, Mense S. Anatomical background of low back pain: Variability and degeneration of the lumbar spinal canal and intervertebral disc. Schmerz 2001; 15:418-424.
123. Takase K, Sawamura Y, Igarashi K, Chiba Y, Haga K, Saito H, Takahashi S. Demonstration of the artery of Adamkiewicz at multi-detector row helical CT. Radiology 2002; 223:39-45.
124. Botwin KP, Gruber RD, Bouchlas CG, Torres-Ramos FM, Freeman TL, Slaten WK. Complications of fluoroscopically guided transforaminal lumbar epidural injections. Arch Phys Med Rehabil 2000; 81:1045-1050.
125. Karaman H, Kavak GO, Tüfek A, Yldrm ZB. The complications of transforaminal lumbar epidural steroid injections. Spine (Phila Pa 1976) 2011; 36:E819-E824.
126. Akkaya T, Sayin M. Transforaminal epidural steroid injection and its complications. Agri 2005; 17:27-39.
127. Furman MB, O'Brien EM, Zgleszewski TM. Incidence of intravascular penetration in transforaminal lumbosacral epidural steroid injections. Spine (Phila Pa 1976) 2000; 25:2628-2632.
128. Goodman BS, Bayazitoglu M, Mallempati S, Noble BR, Geffen JF. Dural puncture and subdural injection: A complication of lumbar transforaminal epidural injections. Pain Physician 2007; 10:697-705.
129. Kabbara A, Rosenberg SK, Untal C. Methicillin-resistant Staphylococcus aureus epidural abscess after transforaminal epidural steroid injection. Pain Physician 2004; 7:269-272.
130. Goodman BS, Posecion LWF, Mallempati S, Bayazitoglu M. Complications and pitfalls of lumbar interlaminar and transforaminal epidural injections. Curr Rev Musculoskelet Med 2008; 1:212-222.
131. Candido KD, Knezevic N'. Cervical epidural steroid injections for the treatment of cervical spinal (neck) pain. Curr Pain Headache Rep 2013; 17:314.
132. Wilkinson IM, Cohen SP. Epidural steroid injections. Curr Pain Headache Rep 2012; 16:50-59.
133. Current Procedural Terminology. CPT 2002, American Medical Association, Chicago, 2001.
134. Centers for Medicare and Medicaid Services (CMS) Manual System. Pub. 100-08 Medicare Program Integrity Manual. www.cms.gov/Regulations-and-Guidance/ Guidance/Manuals/Internet-Only-Manuals-IOMs-Items/CMS019033.html
135. Medicare Program Integrity Manual. Chapter 13-Local Coverage Determinations. Rev. 443, December 14, 2012.
136. Neumann PJ, Chambers JD. Medicare's enduring struggle to define "reasonable and necessary" care. N Engl J Med 2012; 367:1775-1777.
137. Fox J. The hidden role of cost: Medicare decisions, transparency and public trust. Univ Cinci Law Rev 2010; 79:1-51.
138. Neumann PJ, Weinstein MC. Legislating against use of cost-effectiveness information. N Engl J Med 2010; 363:1495-1497.
139. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276:1253-1258.
140. Manchikanti L, Falco FJ, Benyamin RM, Helm S 2nd, Parr AT, Hirsch JA. The impact of comparative effectiveness research on interventional pain management: Evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute. Pain Physician 2011; 14:E249-E282.
141. Chambers JD, Neumann PJ, Buxton MJ. Does Medicare have an implicit cost-effectiveness threshold? Med Decis Making 2010; 30:E14-E27.
142. Medicare Program Integrity Manual Exhibits. Exhibit 3-Description of CAC Members (Rev. 106, Issued: 03-04-05, Effective: 02-01-05, Implementation: 04-04-05). 3.1-Physicians (Rev. 220, Issued: 08-24-07, Effective: 09-03-07, Implementation: 09-03-07).
143. US Department of Health and Human Services. Centers for Medicare and Medicaid Services (CMS) Manual System. Pub. 100-08 Medicare Program Integrity. Inclusion of Interventional Pain Management Specialists on Carrier Advisory Committee (CAC) Membership. Change request 3721. Effective date: February 1, 2005. www.cms.hhs.gov/transmittals/ downloads/R106PI.pdf
144. Manchikanti L, Falco FJE, Singh V, Benyamin RM, Racz GB, Helm S, Caraway DL, Calodney AK, Snook LT, Smith HS, Gupta S, Ward SP, Grider JS, Hirsch JA. An update of comprehensive evidence-based guidelines for interventional techniques of chronic spinal pain. Part I: Introduction and general considerations. Pain Physician 2013; 16:S1-S48.
145. Foote SB, Town RJ. Implementing evidence-based medicine through medicare coverage decisions. Health Aff (Millwood) 2007; 26:1634-1642.
146. Wennberg JE. Practice variations and health care reform: Connecting the dots. Health Aff (Millwood) 2004; Suppl Variation:VAR140-144.
147. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. Part 1: The content, quality, and accessibility of care. An Intern Med 2003; 138:273-287.
148. Kaul S, Diamond GA. Drug-eluting stents. Am Heart Hosp J 2007; 5:165-168. The CMS national coverage decision (NCD) addresses percutaneous transluminal angioplasty (PTA) with and without stenting. See the NCD for PTA (no. 20.7) posted on the CMS Medicare Coverage Database, www.cms.hhs.gov/mcd/viewncd.asp?ncd_ id=20.7&ncd_version=3&basket+ncd%3. New codes were developed for billing for bare metal and drug-coated stents.
149. Feder BJ. Newer stents pose dangers, two doctors say. New York Times, October 12, 2006. www.ny t imes. com/2006/ 10/ 12/ health/12stent.html?_r=0
150. Foote SB, Virnig BA, Town RJ, Hartman L. The impact of Medicare coverage policies on health care utilization. Health Serv Res 2008; 43:1285-1301.
151. Kentucky Cabinet for Health and Family Services. Department of Medicaid Services. http://www.chfs.ky.gov/dms
152. Texas Health and Human Services Commission. Texas Medicaid Program. http:// www.hhsc.state.tx.us/medicaid/
153. California Department of Health and Human Services. Medi-Cal. http://www.dhcs. ca.gov/services/medi-cal/Pages/default. aspx
154. Ohio Department of Medicaid. http:// medicaid.ohio.gov/
155. Oregon Health Authority. Oregon's Medicaid State Plan. http://www.oregon.gov/ oha/healthplan/pages/stateplan.aspx
156. HAYES, Inc. Independent Health Technology Assessment Company. http:// www.hayesinc.com
157. Milliman Care Guidelines. http://www.careguidelines. com/
158. CoventryCares of Kentucky, Kentucky Medicaid. http://chcmedicaid-kentucky. coventryhealthcare.com/
159. WellCare, Kentucky Medicaid. https:// kentucky.wellcare.com/
160. Passport Health Plan, Kentucky Medicaid. http://www.passporthealthplan.com/
161. Humana CareSource, Kentucky Medicaid. https://www.caresource.com/members/ kentucky/
162. Anthem Blue Cross Blue Shield (BCBS), Health and Medical Insurance: www.anthem. com
163. Aetna, Health and Medical Insurance. www.aetna.com/index.htm
164. Cigna, Health and Medical Insurance. www.cigna.com
165. UnitedHealthcare, Health and Medical Insurance. http://www.uhc.com/live/uhc_ com/Assets/Documents/landing.html
166. Bluegrass Family Health, Health and Medical Insurance. http://www.bgfh.com/
167. ECRI Institute. https://www.ecri.org/Pages/ default.aspx
168. American College of Occupational and Environmental Medicine (ACOEM) Chronic Pain. In Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recovery of Workers, Second Edition. American College of Occupational and Environmental Medicine Press, Elk Grove Village, 2008.
169. Dennison PL, Kennedy CW. Official Disability Guidelines. 16th ed. Work Loss Data Institute, Encinitas, 2011.
170. Department of Health and Human Services, Health Care Financing Administration. 42 CFR Parts 410, 411, 414, 415, and 485. Medicare Program; Revisions to payment policies under the physician fee schedule for Calendar Year 2000; Final Rule. November 2, 1999.
171. Department of Health and Human Services, Health Care Financing Administration. 42 CFR Parts 410 and 414 Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2001; Final Rule. November 1, 2000.
172. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 405, 410, 411, 414, and 415. Medicare Program; Revisions to Payment Policies and Five-Year Review of and Adjustments to the Relative Value Units Under the Physician Fee Schedule for Calendar Year 2002; Final Rule. November 1, 2001.
173. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 403, 405, 410, 411, 414, 418, 424, 484, and 486. Medicare Program; Medicare Payment Policies Under the Physician Fee Schedule for Calendar Year 2005; Final Rule. November 15, 2004.
174. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 405, 410, 411, 413, 414, 424, and 426. Medicare Program; Medicare Payment Policies Under the Physician Fee Schedule for Calendar Year 2006 and Certain Provisions Related to the Competitive Acquisition Program of Outpatient Drugs and Biologicals Under Part B; Final Rule. November 21, 2005.
175. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 405, 410, 411, 414, 415, and 424. Medicare Program; Medicare Payment Policies, Five-Year Review of Work Relative Value Units, Changes to the Practice Expense Methodology Under the Physician Fee Schedule, and Other Changes to Payment Under Part B; Revisions to the Payment Policies of Ambulance Services Under the Fee Schedule for Ambulance Services; and Ambulance Inflation Factor Update for CY 2007; Final Rule. December 1, 2006.
176. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 405, 409, 410, 411, 414, 415, 424, 485, and 486. Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; E-Prescribing Exemption for Computer-Generated Facsimile Transmissions; and Payment for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Final Rule. November 19, 2008.
177. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 411, 414, et al. Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010; Final Rule; Medicare Program; Solicitation of Independent Accrediting Organizations to Participate in the Advanced Diagnostic Imaging Supplier Accreditation Program Notice; Final Rule. November 25, 2009.
178. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 405, 409, 410, 411, 413, 414, 415, and 424 Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Final Rule. November 29, 2010.
179. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 414, 415, and 495. Medicare Program; Payment Policies Under the Physician Fee Schedule, Five-Year Review of Work Relative Value Units, Clinical Laboratory Fee Schedule: Signature on Requisition, and Other Revisions to Part B for CY 2012; Final Rule. November 28, 2011.
180. Department of Health and Human Ser vices, Centers for Medicare & Medicaid Services. 42 CFR Part 416. Medicare Program; Update of Ambulatory Surgical Center List of Covered Procedures; Proposed Rule. November 26, 2004.
181. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Part 416. Medicare Program; Update of Ambulatory Surgical Center List of Covered Procedures; Interim Final Rule. May 4, 2005.
182. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 416 et al. Medicare Program-Revisions to Hospital Outpatient Prospective Payment System and Calendar Year 2007 Payment Rates; Final Rule. November 24, 2006.
183. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 416, and 419. Medicare Program: Changes to the Hospital Outpatient Prospective Payment System and CY 2009 Payment Rates; Changes to the Ambulatory Surgical Center Payment System and CY 2009 Payment Rates; Hospital Conditions of Participation: Requirements for Approval and Re-Approval of Transplant Centers to Perform Organ Transplants-Clarification of Provider and Supplier Termination Policy Medicare and Medicaid Programs: Changes to the Ambulatory Surgical Center Conditions for Coverage; Final Rule. November 18, 2008.
184. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 416, and 419 Medicare Program: Changes to the Hospital Outpatient Prospective Payment System and CY 2010 Payment Rates; Changes to the Ambulatory Surgical Center Payment System and CY 2010 Payment Rates; Final Rule. November 20, 2009.
185. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 411, 412, 413, 416, 419, and 489. Medicare Program: Hospital Outpatient Prospective Payment System and CY 2011 Payment Rates; Ambulatory Surgical Center Payment System and CY 2011 Payment Rates; Payments to Hospitals for Graduate Medical Education Costs; Physician Self-Referral Rules and Related Changes to Provider Agreement Regulations; Payment for Certified Registered Nurse Anesthetist Services Furnished in Rural Hospitals and Critical Access Hospitals; Final Rule. November 24, 2010.
186. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 411, 416, 419, 489, and 495. Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment; Ambulatory Surgical Center Payment; Hospital Value-Based Purchasing Program; Physician Self-Referral; and Provider Agreement Regulations on Patient Notification Requirements. Final Changes to the Hospital Outpatient Prospective Payment System and CY 2012 Payment Rates. November 30, 2011.
187. Manchikanti L, Singh V, Hirsch JA. Saga of payment systems of ambulatory surgery centers for interventional techniques: An update. Pain Physician 2012; 15:109-130.
188. Hirsch JA, Rosman DA, Liu RW, Ding A, Manchikanti L. Sustainable growth rate 2013: Time for definitive intervention. J Neurointerv Surg 2013; 5:382-386.
189. Manchikanti L, Singh V, Caraway DL, Benyamin RM, Falco FJE, Hirsch JA. Proposed physician payment schedule for 2013: Guarded prognosis for interventional pain management. Pain Physician 2012; 15:E615-E627.
190. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 405, 410, 411, 414, 423, and 425. Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other Revisions to Part B for CY 2014; Proposed Rule. June 26, 2013.
191. Department of Health and Human Services, Centers for Medicare & Medicaid Services. 42 CFR Parts 405, 410, 412, 416, 419, 475, 476, 486, and 495. Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Organ Procurement Organizations; Quality Improvement Organizations; Electronic Health Records (EHR) Incentive Program; Provider Reimbursement Determinations and Appeals; Proposed Rule. June 26, 2013.
192. Manchikanti L, Benyamin RM, Falco FJE, Hirsch JA. Recommendations of the Medicare Payment Advisory Commission (MedPAC) on the health care delivery system: The impact of interventional pain management in 2014 and beyond. Pain Physician 2013; 16:419-440.
193. Dutton A. The cost of doctor buyouts: Charges rise, patient choice suffers, critics say. Idaho Statesman, October 28, 2012.
194. Mathews AW. Same doctor visit, double the cost: Insurers say rates can surge after hospitals buy private physician practices; Medicare spending rises, too. Wall Street Journal, August 27, 2012.
195. Schulte F. Hospitals face increased scrutiny for charging facility fees. Washington Post, December 23, 2012.
196. Department of Health and Human Services, Centers for Medicare & Medicaid Services. CMS-3234-N, Medicare Program; Renewal of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC), Notice. Federal Register, Wednesday, Deecember 8, 2010.
197. Centers for Medicare and Medicaid Services. Medicare Evidence Development & Coverage Advisory Committee. www.cms. gov/Regulations-and-Guidance/Guidance/ FACA/MEDCAC.html
198. Field MJ, Lohr KN, eds. Clinical Practice Guidelines: Directions for a New Program. Institute of Medicine, National Academy Press, Washington, DC, 1990.
199. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E (eds); Committee on Standards for Developing Trustworthy Clinical Practice Guidelines; Institute of Medicine. Clinical Practice Guidelines We Can Trust. The National Academies Press, Washington, DC, 2011.
200. Institute of Medicine (IOM). Finding What Works in Health Care: Standards for Systematic Reviews. The National Academies Press, Washington, DC, March 23, 2011.
201. Staal JB, de Bie R, de Vet HC, Hildebrandt J, Nelemans P. Injection therapy for subacute and chronic low-back pain. Cochrane Database Syst Rev 2008; 3:CD001824.
202. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 1. Basic considerations. Pain Physician 2010; 13:E23-E54.
203. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 2. Implications for interventional pain management. Pain Physician 2010; 13:E55-E79.
204. Louhiala P, Puustinen R. Rethinking the placebo effect. J Med Ethics 2008; 34:107-109.
205. Louhiala P. The ethics of the placebo in clinical practice revisited. J Med Ethics 2009; 35:407-409.
206. Quill TE, Holloway RG. Evidence, preferences, recommendations-finding the right balance in patient care. N Engl J Med 2012; 366:1653-1655.
207. Gelijns AC, Gabriel SE. Looking beyond translation-integrating clinical research with medical practice. N Engl J Med 2012; 366:1659-1661.
208. Blease C. The principle of parity: The "placebo effect" and physician communication. J Med Ethics 2012; 38:199-203.
209. Häuser W, Bartram C, Bartram-Wunn E, Tölle T. Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: Systematic review. Clin J Pain 2012; 28:437-451.
210. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. CMAJ 1988; 138:697-703.
211. Lyby PS, Forsberg JT, Asli O, Flaten MA. Induced fear reduces the effectiveness of a placebo intervention on pain. Pain 2012; 153:1114-1121.
212. Bisby MA. Inhibition of axonal transport in nerves chronically treated with local anesthetics. Exp Neurol 1975; 47:481-489.
213. Howick J, Bishop FL, Heneghan, Wolstenholme J, Stevens S, Hobbs FDR, Lewith G. Placebo use in the United Kingdom: Results from a national survey of primary care practitioners. PLOS One 2013; 8:e58247.
214. Hróbjartsson A, Kaptchuk TJ, Miller FG. Placebo effect studies are susceptible to response bias and to other types of biases. J Clin Epidemiol 2011; 64:1223-1229.
215. Beecher HK. The powerful placebo. J Am Med Assoc 1955; 159:1602-1606.
216. Hróbjartsson A. What are the main methodological problems in the estimation of placebo effects. J Clin Epidemiol 2002; 55:430-435.
217. Kienle GS, Kiene H. The powerful placebo effect: Fact or fiction? J Clin Epidemiol 1997; 50:1311-1318.
218. Krogsbøll LT, Hróbjartsson A, Gøtzsche PC. Spontaneous improvement in randomised clinical trials: Meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol 2009; 9:1.
219. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Choice of Control Group and Related Issues in Clinical Trials E10. July 20, 2000.
220. Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 3: Systematic reviews and meta-analysis of randomized trials. Pain Physician 2009; 12:35-72.
221. Manchikanti L, Giordano J, Fellows B, Hirsch JA. Placebo and nocebo in interventional pain management: A friend or a foe-or simply foes? Pain Physician 2011; 14:E157-E175.
222. Goffaux P, Léonard G, Marchand S, Rainville P. Placebo analgesia. In: Beaulieu P, Lussier D, Porreca F, Dickenson AH (eds). Pharmacology of Pain. IASP Press, Seattle, 2010, pp 451-473.
223. Iversen T, Solberg TK, Romner B, Wilsgaard T, Twisk J, Anke A, Nygaard O, Hasvold T, Ingebrigtsen T. Effect of caudal epidural steroid or saline injection in chronic lumbar radiculopathy: Multicentre, blinded, randomised controlled trial. BMJ 2011; 343:d5278.
224. Pasqualucci A. Experimental and clinical studies about the preemptive analgesia with local anesthetics. Possible reasons of the failure. Minerva Anestesiol 1998; 64:445-457.
225. Arner S, Lindblom U, Meyerson BA, Molander C. Prolonged relief of neuralgia after regional anesthetic block. A call for further experimental and systematic clinical studies. Pain 1990; 43:287-297.
226. Lavoie PA, Khazen T, Filion PR. Mechanisms of the inhibition of fast axonal transport by local anesthetics. Neuropharmacology 1989; 28:175-181.
227. Cassuto J, Sinclair R, Bonderovic M. Anti-inflammatory properties of local anesthetics and their present and potential clinical implications. Acta Anaesthesiol Scand 2006; 50:265-282.
228. Melzack R, Coderre TJ, Katz J, Vaccarino AL. Central neuroplasticity and pathological pain. Ann N Y Acad Sci 2001; 933:157-174.
229. Manchikanti KN, Pampati V, Damron KS, McManus CD. A double-blind, controlled evaluation of the value of Sarapin in neural blockade. Pain Physician 2004; 7:59-62.
230. Pham Dang C, Lelong A, Guilley J, Nguyen JM, Volteau C, Venet G, Perrier C, Lejus C, Blanloeil Y. Effect on neurostimulation of injectates used for perineural space expansion before placement of a stimulating catheter: Normal saline versus dextrose 5% in water. Reg Anesth Pain Med 2009; 34:398-403.
231. Tsui BCH, Wagner, A, Finucane B. Electrophysiologic effect of injectates on peripheral nerve stimulation. Reg Anesth Pain Med 2004; 29:189-193.
232. Pham Dang C, Guilley J, Dernis L, Langlois C, Lambert C, Nguyen JM, Pin aud M. Is there any need for expanding the perineural space before catheter placement in continuous femoral nerve blocks? Reg Anesth Pain Med 2006; 31:393-400.
233. Pham Dang C, Kick O, Collet T, Gouinn F, Pinaud M. Continuous peripheral nerve blocks with stimulating catheters. Reg Anesth Pain Med 2003; 28:83-88.
234. Tsui BC, Kropelin B. The electrophysiologic effect of dextrose 5% in water on single-shot peripheral nerve stimulation. Anesth Analg 2005; 100:1837-1839.
235. Bresnahan BW, Rundell SD, Dagadakis MC, Sullivan SD, Jarvik JG, Nguyen H, Friedly JL. A systematic review assessing comparative effectiveness studies in epidural steroid injections for lumbar spinal stenosis and to estimate reimbursement amounts. PM R 2013; 5:705-714.